日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Modulation of Tumor-Treating Fields by Cerebral Edema from Brain Tumors

脑肿瘤引起的脑水肿对肿瘤治疗电场的调节

Lok, Edwin; Clark, Matthew; Liang, Olivia; Malik, Talbia; Koo, Sophia; Wong, Eric T

Social Networks and HIV Care Outcomes in Rural Kenya and Uganda

肯尼亚和乌干达农村地区的社交网络与艾滋病毒感染者护理结果

Chen, Yiqun T; Brown, Lillian; Chamie, Gabriel; Kwarisiima, Dalsone; Ayieko, James; Kabami, Jane; Charlebois, Edwin; Clark, Tamara; Kamya, Moses; Havlir, Diane V; Petersen, Maya L; Balzer, Laura B

BRD4 amplification facilitates an oncogenic gene expression program in high-grade serous ovarian cancer and confers sensitivity to BET inhibitors

BRD4 扩增促进高级别浆液性卵巢癌中的致癌基因表达程序并赋予对 BET 抑制剂的敏感性

Garrett W Rhyasen, Yi Yao, Jingwen Zhang, Austin Dulak, Lillian Castriotta, Kelly Jacques, Wei Zhao, Farzin Gharahdaghi, Maureen M Hattersley, Paul D Lyne, Edwin Clark, Michael Zinda, Stephen E Fawell, Gordon B Mills, Huawei Chen

Potent and selective bivalent inhibitors of BET bromodomains

强效且选择性的 BET 溴结构域双价抑制剂

Michael J Waring, Huawei Chen, Alfred A Rabow, Graeme Walker, Romel Bobby, Scott Boiko, Rob H Bradbury, Rowena Callis, Edwin Clark, Ian Dale, Danette L Daniels, Austin Dulak, Liz Flavell, Geoff Holdgate, Thomas A Jowitt, Alexey Kikhney, Mark McAlister, Jacqui Méndez, Derek Ogg, Joe Patel, Philip Pet

Acquired savolitinib resistance in non-small cell lung cancer arises via multiple mechanisms that converge on MET-independent mTOR and MYC activation

非小细胞肺癌中沃利替尼获得性耐药的产生是通过多种机制实现的,这些机制均以 MET 独立的 mTOR 和 MYC 激活为核心

Ryan E Henry, Evan R Barry, Lillian Castriotta, Brendon Ladd, Aleksandra Markovets, Garry Beran, Yongxin Ren, Feng Zhou, Ammar Adam, Michael Zinda, Corinne Reimer, Weiguo Qing, Weiguo Su, Edwin Clark, Celina M D'Cruz, Alwin G Schuller

Prevalence of asymptomatic parasitemia and gametocytemia among HIV-infected Ugandan children randomized to receive different antiretroviral therapies

在随机接受不同抗逆转录病毒疗法的乌干达 HIV 感染儿童中,无症状寄生虫血症和配子体血症的患病率

Ikilezi, Gloria; Achan, Jane; Kakuru, Abel; Ruel, Theodore; Charlebois, Edwin; Clark, Tamara D; Rosenthal, Philip J; Havlir, Diane; Kamya, Moses R; Dorsey, Grant

The mechanisms of differential sensitivity to an insulin-like growth factor-1 receptor inhibitor (BMS-536924) and rationale for combining with EGFR/HER2 inhibitors

胰岛素样生长因子-1受体抑制剂(BMS-536924)的差异敏感性机制以及与EGFR/HER2抑制剂联合使用的原理

Fei Huang, Ann Greer, Warren Hurlburt, Xia Han, Rameh Hafezi, Gayle M Wittenberg, Karen Reeves, Jiwen Chen, Douglas Robinson, Aixin Li, Francis Y Lee, Marco M Gottardis, Edwin Clark, Lee Helman, Ricardo M Attar, Ashok Dongre, Joan M Carboni